FIELD: medicine.
SUBSTANCE: stage of atopic dermatitis in children is diagnosed by immunobiological assay of patient's peripheral blood. A degree of lymphocyte expression of CD95+ markers is evaluated. If the CD95+ value exceeds 60.09% enables diagnosing an acute stage of the disease, while the CD95+ values 20.33% to 60.09% shows a chronic stage.
EFFECT: well-timed prediction of the clinical course ensured by accuracy and acceleration of dianosis of transmission of the acute stage of atopic dermatitis in children into the chronic stage.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2019 |
|
RU2711746C1 |
| METHOD FOR DIAGNOSING ATOPIC DERMATITIS IN SCHOOLCHILDREN ASSOCIATED WITH THE COMPLEX EFFECTS OF TECHNOGENIC CHEMICAL COMPOUNDS: FORMALDEHYDE AND BENZO(A)PYRENE, WITH THE PRESENCE OF NEGATIVE FACTORS IN THE EDUCATIONAL ENVIRONMENT AND LIFESTYLE, AND WITH A VIOLATION OF THE NUTRITION STRUCTURE | 2022 |
|
RU2784352C1 |
| METHOD FOR DETERMINING THE STAGE OF ATOPIC DERMATITIS | 2021 |
|
RU2772411C1 |
| METHOD FOR PREDICTION OF THE RISK OF INFECTIOUS COMPLICATIONS IN ATOPIC DERMATITIS | 2018 |
|
RU2694223C1 |
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2017 |
|
RU2677481C1 |
| METHOD OF PREDICTING DEGREE OF ATOPIC DERMATITIS IN CHILDREN | 2016 |
|
RU2630063C1 |
| METHOD FOR PREDICTION OF CHILDREN ATOPIC DERMATITIS RISK | 2019 |
|
RU2703546C1 |
| METHOD FOR DETERMINATION OF IMMUNOPATHOLOGICAL RESPONSE TYPE IN CHILDREN WITH ATOPIC DERMATITIS | 2008 |
|
RU2384298C1 |
| METHOD FOR PREDICTING CHRONIC PYELONEPHRITIS IN CHILDREN | 2006 |
|
RU2314039C1 |
| METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF BRONCHIAL ASTHMA | 2008 |
|
RU2389023C2 |
